Advertisement

Topics

Latest "Bavarian Nordic Announces Initiation Phase Booster Study Universal" News Stories - Page: 5

08:14 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Bavarian Nordic Announces Initiation Phase Booster Study Universal" found in our extensive news archives from over 250 global news sources.

More Information about Bavarian Nordic Announces Initiation Phase Booster Study Universal on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Bavarian Nordic Announces Initiation Phase Booster Study Universal for you to read. Along with our medical data and news we also list Bavarian Nordic Announces Initiation Phase Booster Study Universal Clinical Trials, which are updated daily. BioPortfolio also has a large database of Bavarian Nordic Announces Initiation Phase Booster Study Universal Companies for you to search.

Showing "Bavarian Nordic Announces Initiation Phase Booster Study Universal" News Articles 101–125 of 32,000+

Friday 22nd March 2019

Ovary function is preserved in transgender men at one year of testosterone therapy

(The Endocrine Society) Transgender men preserve their fertility potential even after one year of treatment with the male hormone testosterone, according to a study that will be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.


Another possible consequence of the opioid epidemic: hormone deficiencies

(The Endocrine Society) Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study. Results of what the researchers called "the most up-to-date and most comprehensive clinical review of endocrine effects of long-term opioid use" are being presented Sunday at ENDO 2019, the Endocrine Society's annual meeting i...

Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting

-Post-hoc analysis suggests abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concurrent osteoarthritis, at high risk for fracture- -Preclinical studies provide explanations for the net bone gain observed in the Phase 3 ACTIVE trial in abaloparatide-treated patients- WALTHAM, Mass., March 23, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS)...


Improved PCOS symptoms correlate with gut bacterial composition

(The Endocrine Society) Symptoms of polycystic ovary syndrome (PCOS) improved with exposure to healthy bacteria in the gut, according to a study in a mouse model of this common women's endocrine disorder. The study results will be presented Monday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

A1c test misses many cases of diabetes

(The Endocrine Society) Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

Medical News Today: Could prescription vegetables be the future of healthcare?

A recent study investigates whether prescribing healthful food could, in time, save money and improve health. The results are surprising.

New hybrid closed loop insulin pump proves hard to use for some patients with diabetes

(The Endocrine Society) Among first-time users of a new insulin pump that automatically delivers insulin to people with type 1 diabetes, nearly one-fifth stopped using the device, primarily because of difficulties meeting the technical demands system, researchers say. Results of a real-world study of the hybrid closed loop insulin pump (Medtronic MiniMed 670G) will be presented Sunday at the Endoc...

Now Cashed Up, Biopharma to Advance Cholesterol-Lowering Therapy

Source: Streetwise Reports   03/23/2019 A ROTH Capital Partners report reviewed this New Jersey firm's plans for its lead asset.In a March 21 research note, ROTH Capital Partners analyst Jerry Isaacson reported that Matinas BioPharma Holdings Inc. (MTNB:OTC.MKTS) is "positioned for success" following its equity raise, "executed under favorable terms." Expected gross pr...

. @UCSF investigators publish study showing that individuals diagnosed with peripheral artery disease have a lower #omega3 Index compared to those who don’t have the disease: http://ow.ly/RWLD30o8sdx 

. @UCSF investigators publish study showing that individuals diagnosed with peripheral artery disease have a lower #omega3 Index compared to those who don’t have the disease: http://ow.ly/RWLD30o8sdx 

AAHRPP Accredits Three More Research Organizations

Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs today announced its first accreditations for 2019: a research institute in Massachusetts, a health care delivery system in California and a hospital in Taiwan. The three newly accredited organiza...

Screening Ultrasonography Does Not Improve Breast-cancer Detection

Rates of breast-cancer detection are similar after screening mammography with or without screening ultrasonography, according to an observational study. Reuters Health Information

Healthcare Special Opportunities Fund Announces March 2019 Quarterly Distribution

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 22, 2019 (GLOBE NEWSWIRE) — (TSX: MDS.UN) – LDIC Inc. (the “Manager”), the manager of Healthcare Special Opportunities Fund (the “Fund”), a closed-end investment … Continue reading →

WuXi AppTec Reports Strong 2018 Annual Results

Revenue RMB9,614 Million, up 23.8% (25.4% at Constant Exchange Rate) Year-Over-Year Net Profit Attributable to Owners of the Company RMB2,261 Million, up 84.2% Year-Over-Year Diluted EPS RMB 2.21, up 70.0% Year-Over-Year SHANGHAI, March 22, 2019 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 0235...

Society for Immunotherapy of Cancer Announces 2019 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship

The Society for Immunotherapy of Cancer (SITC) is pleased to announce Olivera J. Finn, PhD, University of Pittsburgh Distinguished Professor of Immunology and Surgery and Founding Chair of the university’s Department of Immunology, as the 2019 recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship, the society’s highest honor. MILWAUKEE (PRWEB) March 22, 2019 The Society for ...

Kadmon Holdings, Inc.: Kadmon Announces Susan Wiviott to Step Down from Board of Directors

NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott does not intend to stand for re-election to Kadmon's Board of Directors at the upc...

Gossamer Bio Announces 2018 Annual Financial Results

Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the year ended December 31, 2018 and provided an update on recent corporate developments. ...

Imago BioSciences raises $40mm in Series B round

Imago BioSciences Inc. (developing treatments for proliferative bone marrow diseases) raised $40mm in its Series B round. Ome...

Yet again an amyloid-targeting drug fails in phase 3. Read our story about the thousands of amyloid isoforms in brain tissue, a finding that could mean such agents are doomed https://www.nature.com/articles/s41587-019-0029-y …pic.twitter.com/cAnUgyTal

Yet again an amyloid-targeting drug fails in phase 3. Read our story about the thousands of amyloid isoforms in brain tissue, a finding that could mean such agents are doomed https://www.nature.com/articles/s41587-019-0029-y … pic.twitter.com/cAnUgyTalv

Analysis IDs Messages Behind Antivaccination Comments

FRIDAY, March 21, 2019 -- Arguments against vaccination remain consistent within subgroups of individuals, according to a study published online March 18 in Vaccine. Beth L. Hoffman, from the University of Pittsburgh School of Medicine, and...

Stricter Gun Laws Tied to Safer High Schools

FRIDAY, March 22, 2019 -- The adoption of stricter state gun laws is associated with improvements in school climate, including fewer students carrying weapons, according to a study published online March 21 in the Journal of Epidemiology &...

Understanding how people respond to symptoms of a brain tumour

A study has highlighted that people may experience multiple subtle changes before being diagnosed with a brain tumour. The study focused on these changes as missed opportunities to diagnose brain tumours earlier and how increased awareness of these...

The Week That Wasn't: Brain Infection, Plastic Surgery Rates, Memory and Intelligence

Find out about a man who developed an infection in the lining of his brain after cleaning his ears, details on a plastic surgery annual statistics report, and a study suggesting that forgetfulness is a sign of intelligence. Medscape

Edison Investment Research Limited: Edison Issues Outlook on Sunesis Pharmaceuticals (SNSS)

LONDON, UK / ACCESSWIRE / March 22, 2019 / Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) is currently in the dose-escalation portion of the Phase Ib/II study of its BTK inhibitor vecabrutinib, and t...

Assure Holdings Announces Estimated Impact from Fourth Quarter 2018 Increase in Bad Debt Expense

DENVER, March 22, 2019 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced today that it was increasing its estimate for bad debt expense during the fourth quarter … Continue reading →

AUDIO: Podcast: Gottlieb Addresses LDT Legislation At Brookings

US FDA Commissioner Scott Gottlieb spoke with Medtech Insight about the agency’s decision to put the LDT issue to Congress...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks